Do you want to read an article? Please log in or register.
Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial
COPD
COMMENTED
Related content
ERS 2024
Asthma
TRAVERSE: Dupilumab reduces severe asthma exacerbation rates and improves lung function regardless of increases in blood eosinophil counts
RECOMMENDED
Further Publications
Rethinking Blood Eosinophils for Assessing ICS Response in COPD: A Post-Hoc Analysis from FLAME
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Mathioudakis AG, Bate S, Sivapalan P, Stæhr Jensen JU, Singh D, Vestbo J
doi: 10.1016/j.chest.2024.06.3790
RECOMMENDED
Further Publications
Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Muro S, Kawayama T, Sugiura H, Seki M, Duncan EA, Bowen K, Marshall J, Megally A, Patel M
doi: 10.1186/s12931-024-02918-8
COPD
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials
Ther Adv Respir Dis
Hammadeh BM, Younis OM, Alsufi MI, Idrees M, Hussein AM, Aldalati AY, Qtaishat FA, Qatawneh B, Bugazia A, Hamed RA
doi: 10.1177/17534666251347775
RECOMMENDED
AsthmaCOPD
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Ramakrishnan S, Russell REK, Mahmood HR, Krassowska K, Melhorn J, Mwasuku C, Pavord ID, Bermejo-Sanchez L, Howell I, Mahdi M, Peterson S, Bengtsson T, Bafadhel M
doi: 10.1016/S2213-2600(24)00299-6
COMMENTED
COPD
Nasal High Flow or Noninvasive Ventilation? Navigating Hypercapnic COPD Exacerbation Treatment: A Randomized Noninferiority Clinical Trial
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Pantazopoulos I, Boutlas S, Mavrovounis G, Papalampidou A, Papagiannakis N, Kontou M, Bibaki E, Athanasiou N, Meletis G, Gourgoulianis K, Zakynthinos S, Ischaki E
doi: 10.1016/j.rmed.2024.107762
Lung Cancer
Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors
Clin Lung Cancer
Bodor JN, Dowell J, Treat J, Subramanian J, Abdulla N, Lee E, Sankhala K, Lee CH, Makimoto G, Miyauchi E, Konduri K, Asahina H, Murakami S, Wen YF, Luo YH, Chang SY, Ewesuedo R, Zhou J, Goto Y
doi: 10.1016/j.cllc.2025.05.013
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
Asthma
Sub-Optimal Disease Control and Low Blood Eosinophil Testing Frequency in Chinese Adult Patients with Asthma Receiving GINA Step 4/5 Treatment: A Real-World Study
J Asthma Allergy
Benson VS, Siddall J, Haq A, Small M, Tang Z, Ye T, Howarth P, Richards A, Alfonso-Cristancho R
doi: 10.2147/JAA.S474338